首页> 美国卫生研究院文献>Antimicrobial Agents and Chemotherapy >In Vitro Activity of Polymyxin B plus Imipenem Meropenem or Tigecycline against KPC-2-Producing Enterobacteriaceae with High MICs for These Antimicrobials
【2h】

In Vitro Activity of Polymyxin B plus Imipenem Meropenem or Tigecycline against KPC-2-Producing Enterobacteriaceae with High MICs for These Antimicrobials

机译:多粘菌素B加亚胺培南美洛培南或替加环素对这些抗菌剂具有高MIC的KPC-2生产肠杆菌科细菌的体外活性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We evaluated the in vitro activity of polymyxin B plus imipenem, meropenem, or tigecycline against six KPC-2-producing Enterobacteriaceae strains with high MICs for these antimicrobial agents. Polymyxin B with carbapenems, especially meropenem, were the most active combinations for Klebsiella pneumoniae and Enterobacter cloacae regardless of the polymyxin B concentration used in the time-kill assay. This combination was also synergistic against two Serratia marcescens strains that are intrinsically resistant to polymyxins. Polymyxin B and tigecycline also presented synergistic activity in most experiments.
机译:我们评估了多粘菌素B加亚胺培南,美洛培南或替加环素对六种具有高MIC的KPC-2产肠杆菌科菌株的体外活性,这些活性为这些抗微生物剂。多聚毒素B与碳青霉烯类,尤其是美罗培南,是肺炎克雷伯菌和阴沟肠杆菌最有效的组合,而与时间杀灭试验中使用的多粘菌素B浓度无关。该组合还对固有地对多粘菌素有抗性的两个粘质沙雷氏菌(Serratia marcescens)菌株具有协同作用。在大多数实验中,多粘菌素B和替加环素也表现出协同活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号